Indeed, silencing of GPR137 resulted in a downregulation of SNAI1/SNAIL and SNAI2/SLUG and a corresponding increase in E-cadherin expression in human prostate cancer cells (Ren et al., 2016). This evidence concerns the gene SNAI2 and prostate cancer.